The latest closing stock price for Denali Therapeutics as of November 20, 2024 is 24.42.
An investor who bought $1,000 worth of Denali Therapeutics stock at the IPO in 2017 would have $138 today, roughly 0 times their original investment - a 1.87% compound annual growth rate over 7 years.
The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
The Denali Therapeutics 52-week high stock price is 33.33, which is 36.5% above the current share price.
The Denali Therapeutics 52-week low stock price is 14.56, which is 40.4% below the current share price.
The average Denali Therapeutics stock price for the last 52 weeks is 21.85.
An investor who bought $1,000 worth of Denali Therapeutics stock at the IPO in 2017 would have $138 today, roughly 0 times their original investment - a 1.87% compound annual growth rate over 7 years.
The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
The Denali Therapeutics 52-week high stock price is 33.33, which is 36.5% above the current share price.
The Denali Therapeutics 52-week low stock price is 14.56, which is 40.4% below the current share price.
The average Denali Therapeutics stock price for the last 52 weeks is 21.85.